1. Aliskiren and Valsartan for Antihypertensive Therapy Trial Presented at the American College of Cardiology Annual Scientific Session March 2007 Presented by Dr. Suzanne Oparil Aliskiren and Valsartan for Antihypertensive Therapy Trial
2.
3.
4. Aliskiren and Valsartan for Antihypertensive Therapy: 4 Week Outcomes *p<0.0001 vs. placebo † p<0.001 vs. aliskiren/valsartan ACC 2007 Placebo Aliskiren + Valsartan Valsartan Aliskiren Week 4 Endpoint -10.7* -7.5* 150 mg n=437 -10.9* † -8.7* † 160 mg n=455 -15.3* -10.5* 150/160 mg n=446 -5.2 Change in SBP (mm Hg) -4.8 Change in DBP (mm Hg) n=459
5. Aliskiren and Valsartan for Antihypertensive Therapy: 8 Week Outcomes *p<0.0001 vs. placebo † p<0.001 vs. aliskiren/valsartan ACC 2007 -4.6 -17.2* -12.8* † -13.0* † Change in SBP (mm Hg) 16.5 49.3* 33.8 * † 37.4 * † BP Control Rate (%) Placebo Aliskiren + Valsartan Valsartan Aliskiren Week 8 Endpoint -9.0* † 300 mg n=437 -9.7* † 320 mg n=455 -12.2* 300/320 mg n=446 -4.1 Change in DBP (mm Hg) n=459